Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,948,284
-$1,015 QoQ
Shares Held
33,516
-0.1% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#140
of 329 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $1,244,853,717 across 210 Biotechnology names. PCVX ranks #55 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
255,073 | $236,649,076 | |
| 2 | INSM |
INSMED Inc
|
1,015,870 | $108,312,059 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
129,981 | $64,565,461 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,166,715 | $63,480,962 | |
| 5 | ASND |
Ascendis Pharma A/S
|
237,869 | $63,444,419 | |
| 6 | INCY |
Incyte Corp
|
498,013 | $56,454,752 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
551,116 | $43,135,848 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60,441 | $37,687,380 |
All Filings in PCVX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,948,284 | 33,516 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,949,299 | 33,545 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,427,571 | 30,940 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,239,926 | 89,948 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,290,939 | 39,709 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,868,656 | 181,903 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $13,235,288 | 161,682 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $20,479,125 | 179,217 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $12,847,950 | 170,149 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,063,457 | 103,403 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $6,490,253 | 103,348 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,189,939 | 121,419 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,285,151 | 65,782 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $818,075 | 21,827 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,061,756 | 22,143 | Shares | Defined | 2023-02-10 | |
| No filing history on record for this holder in this stock. | ||||||